Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Roger

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
The Review of Scientific Instruments|March 3, 2016
Status of the SPIRAL2 injector commissioningT Thuillier, J Angot, C Barué, et al.
Circulation. Genomic and Precision Medicine|April 18, 2025
Diagnostic MicroRNA Signatures to Support Classification of Pulmonary HypertensionNiamh Errington, Li Zhou, Christopher J Rhodes, et al.
Journal of Investigational Allergology & Clinical Immunology|September 18, 2018
Quality Standards for Allergen Immunotherapy Clinics in Spain: Consensus DocumentA I Tabar, B Núñez Acevedo, J M Beitia Mazuecos, et al.
Heart (British Cardiac Society)|May 5, 2022
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment responseZe Ming Goh, Nithin Balasubramanian, Samer Alabed, et al.
Iscience|January 23, 2023
A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3Aneel R Bhagwani, Mehboob Ali, Bryce Piper, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
ERJ Open Research|March 25, 2026
Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
Respirology (Carlton, Vic.)|April 7, 2020
Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: A series of 90 patients from the ASPIRE registryRobert A Lewis, Catherine G Billings, Aidan Bolger, et al.
Annals of the American Thoracic Society|September 14, 2020
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial HypertensionRobert A Lewis, Catherine G Billings, Judith A Hurdman, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
The Review of Scientific Instruments|March 3, 2016
Status of the SPIRAL2 injector commissioningT Thuillier, J Angot, C Barué, et al.
Circulation. Genomic and Precision Medicine|April 18, 2025
Diagnostic MicroRNA Signatures to Support Classification of Pulmonary HypertensionNiamh Errington, Li Zhou, Christopher J Rhodes, et al.
Journal of Investigational Allergology & Clinical Immunology|September 18, 2018
Quality Standards for Allergen Immunotherapy Clinics in Spain: Consensus DocumentA I Tabar, B Núñez Acevedo, J M Beitia Mazuecos, et al.
Heart (British Cardiac Society)|May 5, 2022
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment responseZe Ming Goh, Nithin Balasubramanian, Samer Alabed, et al.
Iscience|January 23, 2023
A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3Aneel R Bhagwani, Mehboob Ali, Bryce Piper, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
ERJ Open Research|March 25, 2026
Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
Respirology (Carlton, Vic.)|April 7, 2020
Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: A series of 90 patients from the ASPIRE registryRobert A Lewis, Catherine G Billings, Aidan Bolger, et al.
Annals of the American Thoracic Society|September 14, 2020
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial HypertensionRobert A Lewis, Catherine G Billings, Judith A Hurdman, et al.
Pageof 18